#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Pulmonary fibrosis Alexander disease Leukodystrophy Adenovirus infection Herpes simplex Leukoencephalopathy Urethral valves Mantle cell lymphoma stage III B-cell small lymphocytic lymphoma Pancreatic carcinoma metastatic Synovial sarcoma recurrent Polycystic liver disease Erythema multiforme Rhabdoid tumour Round cell liposarcoma More trials…
Learn about Rare Diseases

Hepatic angiosarcoma – Basic Information Rhabdomyosarcoma recurrent – Treatment Progressive supranuclear palsy – Treatment Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Wolfram syndrome Prolymphocytic leukaemia – Trials in Disease Andersen-Tawil syndrome – Basic Information Systemic mastocytosis – Basic Information Hereditary motor and sensory neuropathy – Treatment Hereditary neuropathic amyloidosis – Trials in Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Glatiramer Acetate Mecasermin Rinfabate Rineterkib Regn7508 Dotatate 177Lu-Dpi-4452 Ecoo1A Sirexatamab A/H1N1 INFLUENZA VACCINE Chloride Ion BENZYDAMINE HYDROCHLORIDE Azd7798 Mesalazine Yttrium-90 Bms-986288 Aspergillus Fumigatus Ads-011 Terlipressin Etrasimod Arginine Tremelimumab More therapies…

Learn about Your Condition

Tuberculosis Anogenital dysplasia Polymyalgia rheumatica Ocular myasthenia Migraine without aura Neurotrophic keratopathy Lymphocytic lymphoma Krabbe's disease Rheumatoid arthritis Hip fracture Immune-mediated myositis Oesophageal cancer metastatic Osteopenia Limb reduction defect Malignant neoplasm of choroid More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Bladder cancer stage II

Study of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment

Not recruiting

3 1 1
Investigated Diseases:
Investigated Drugs:
+4
Study on Pre-Operative Nivolumab and Relatlimab for Adults with Stage II-IIIa Muscle-Invasive Bladder Cancer

Not recruiting

4 1 1 1
Investigated Diseases:
Investigated Drugs:
- Relatlimab
- Nivolumab

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Bladder cancer stage II

Study of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment

Study on Pre-Operative Nivolumab and Relatlimab for Adults with Stage II-IIIa Muscle-Invasive Bladder Cancer

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies